Promethazine
Promethazine, sold under the brand name Phenergan among others, is a first-generation antihistamine, antipsychotic, sedative, and antiemetic used to treat allergies, insomnia, and nausea. It may also help with some symptoms associated with the common cold and may also be used for sedating people who are agitated or anxious, an effect that has led to some recreational use (especially with codeine). Promethazine is taken by mouth (oral), as a rectal suppository, or by injection into a muscle (IM).
Clinical data | |
---|---|
Trade names | Phenergan, many others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682284 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth, rectal, intravenous, intramuscular, topical |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 88% absorbed but after first-pass metabolism reduced to 25% absolute bioavailability |
Protein binding | 93% |
Metabolism | Liver glucuronidation and sulfoxidation |
Elimination half-life | 10–19 hours |
Excretion | Kidney and biliary |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.445 |
Chemical and physical data | |
Formula | C17H20N2S |
Molar mass | 284.42 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Common side effects of promethazine include confusion and sleepiness; consumption of alcohol or other sedatives can make these symptoms worse. It is unclear if use of promethazine during pregnancy or breastfeeding is safe for the fetus. Use of promethazine is not recommended in those less than two years old, due to potentially negative effects on breathing. Use of promethazine by injection into a vein is not recommended, due to potential skin damage. Promethazine is in the phenothiazine family of medications. It is also a moderate anticholinergic, which produces its sedative effects. This also means high doses act as a deliriant.
Promethazine was made in the 1940s by a team of scientists from Rhône-Poulenc laboratories. It was approved for medical use in the United States in 1951. It is a generic medication and is available under many brand names globally. In 2020, it was the 208th most commonly prescribed medication in the United States, with more than 2 million prescriptions.